SPRINT study : far lower systolic blood pressure
There is still no consensus, which blood pressure value is the most profitable for the patients when treating the systolic hypertension in the context of reduction of cardiovascular events and cardiovascular and overall mortality.Researchers of the ACCORD study were comparing intensive treatment of systolic blood pressure bellow 120 mmHg and standard treatment reaching bellow 140 mmHg and showed no influence of intensive treatment on the primary goal in individuals with diabetes mellitus.Last autumn, SPRINT study was presented and published showing the favourable effect of intensive (i. e. bellow 120 mmHg) blood pressure lowering on combined primary goal which was myocardial infarction, other acute coronary syndromes, ischemic stroke, heart failure or death from cardiovascular reasons. On the other hand, intensive treatment also resulted in statistically significant occurrence of adverse events (hypotension, syncope, renal injury of failure).
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:155 |
|---|---|
| Enthalten in: |
Casopis lekaru ceskych - 155(2016), 4 vom: 25., Seite 9-12 |
| Sprache: |
Tschechisch |
|---|
| Weiterer Titel: |
Studie SPRINT: Kam až snižovat systolický krevní tlak |
|---|
| Beteiligte Personen: |
Souček, Miroslav [VerfasserIn] |
|---|
| Themen: |
Antihypertensive Agents |
|---|
| Anmerkungen: |
Date Completed 30.06.2017 Date Revised 02.12.2018 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM263026477 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM263026477 | ||
| 003 | DE-627 | ||
| 005 | 20231224202958.0 | ||
| 007 | tu | ||
| 008 | 231224s2016 xx ||||| 00| ||cze c | ||
| 028 | 5 | 2 | |a pubmed24n0876.xml |
| 035 | |a (DE-627)NLM263026477 | ||
| 035 | |a (NLM)27481195 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a cze | ||
| 100 | 1 | |a Souček, Miroslav |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SPRINT study |b far lower systolic blood pressure |
| 246 | 3 | 3 | |a Studie SPRINT: Kam až snižovat systolický krevní tlak |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 30.06.2017 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a There is still no consensus, which blood pressure value is the most profitable for the patients when treating the systolic hypertension in the context of reduction of cardiovascular events and cardiovascular and overall mortality.Researchers of the ACCORD study were comparing intensive treatment of systolic blood pressure bellow 120 mmHg and standard treatment reaching bellow 140 mmHg and showed no influence of intensive treatment on the primary goal in individuals with diabetes mellitus.Last autumn, SPRINT study was presented and published showing the favourable effect of intensive (i. e. bellow 120 mmHg) blood pressure lowering on combined primary goal which was myocardial infarction, other acute coronary syndromes, ischemic stroke, heart failure or death from cardiovascular reasons. On the other hand, intensive treatment also resulted in statistically significant occurrence of adverse events (hypotension, syncope, renal injury of failure) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a cardiovascular events | |
| 650 | 4 | |a hypotension. | |
| 650 | 4 | |a systolic blood pressure | |
| 650 | 4 | |a target values | |
| 650 | 7 | |a Antihypertensive Agents |2 NLM | |
| 700 | 1 | |a Řiháček, Ivan |e verfasserin |4 aut | |
| 700 | 1 | |a Novák, Jan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Casopis lekaru ceskych |d 1948 |g 155(2016), 4 vom: 25., Seite 9-12 |w (DE-627)NLM000001805 |x 0008-7335 |7 nnns |
| 773 | 1 | 8 | |g volume:155 |g year:2016 |g number:4 |g day:25 |g pages:9-12 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 155 |j 2016 |e 4 |b 25 |h 9-12 | ||